Plasma Levels of Liver-Specific miR-122 Is Massively Increased in a Porcine Cardiogenic Shock Model and Attenuated by Hypothermia

Abstract

Tissue-specific circulating micro-RNAs (miRNAs) are released into the blood after organ injury. In an ischemic porcine cardiogenic shock model, we investigated the release pattern of cardiac-specific miR-208b and liver-specific miR-122 and assessed the effect of therapeutic hypothermia on their respective plasma levels. Pigs were anesthetized, and cardiogenic shock was induced by inflation of a percutaneous coronary intervention balloon in the proximal left anterior descending artery for 40 min followed by reperfusion. After fulfillment of the predefined shock criteria, the pigs were randomized to hypothermia (33°C, n = 6) or normothermia (38°C, n = 6). Circulating miRNAs were extracted from plasma and measured with quantitative real-time polymerase chain reaction (PCR). Tissue specificity was assessed by miRNA extraction from porcine tissues followed by quantitative real-time PCR. In vitro, the release of miR-122 from a cultured hepatocyte cell line exposed to either hypoxia or acidosis was assessed by real-time PCR. miR-122 was found to be highly liver specific, whereas miR-208b was expressed exclusively in the heart. In the control group, ischemic cardiogenic shock induced a 460,000-fold and a 63,000-fold increase in plasma levels of miR-122 (P < 0.05) and miR-208b (P < 0.05), respectively. Therapeutic hypothermia significantly diminished the increase in miR-122 compared with the normothermic group (P < 0.005). In our model, hypothermia was initiated after coronary reperfusion and did not affect either myocardial damage as previously assessed by magnetic resonance imaging or the plasma level of miR-208b. Our results indicate that liver-specific miR-122 is released into the circulation in the setting of cardiogenic shock and that therapeutic hypothermia significantly reduces the levels of miR-122.

Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction

“…38 It has been also proposed that circulating proteinbound miRNAs are by-products of dead cells, and it seems intuitive that liver ischemia might be implicated in miR-122-5p release. However, like Andersson et al, 24 we did not observe any association between miR-122-5p and liver necrosis biomarkers. Therefore, it remains possible that protein carrier pathways participate in the specific release of these complexes from hepatocytes.…”

“…In a random subset of 40 patients, miRNA levels were also measured at subsequent time points (8,16,24,48 and 72 h after angioplasty). Total RNA was isolated from 300 μl serum by Trizol ® reagent extraction and subsequent RNA purification using the Qiagen's RNAeasy columns as described elsewhere.…”

Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases

“…The levels of miR-221 and miR-222 were decreased whereas levels of miR-21, miR-130a, and some other miRNAs in patients with peripheral arterial disease28. Interestingly, plasma level of liver specific miR-122 was increased significantly after cardiogenic shock29.…”

Serum levels of unique miR-551-5p and endothelial-specific miR-126a-5p allow discrimination of patients in the early phase of acute pancreatitis

“…miR-122 is associated with cardiogenic shock in model systems, and a possible application in laboratory diagnostics of dysfunction in organs other than the liver could be proposed [45]. miR-375 has an unlimited potential for monitoring (in clinics) and understanding (in pathophysiology) the pancreas function.…”